Curtis L. Simmons

Curtis L. Simmons

Auto-generated profile, based on publicly available information

Curtis L. Simmons

Associate Program Director, Pediatric Radiology Fellowship, Phoenix Children's, Phoenix, Arizona

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in RadioGraphics
Verified
Journal Article
Closed access
CSCurtis L. Simmons
Curtis L. Simmons
LHLaura K. Harper
Laura K. Harper
MPMittun C. Patel
Mittun C. Patel
VKVenkat S. Katabathina
Venkat S. Katabathina
RSRichard N. Southard
Richard N. Southard
DBDeepa R. Biyyam
Deepa R. Biyyam
Biliary abnormalities in children are uncommon, and the spectrum of biliary disorders is broader than in adult patients. Unlike in adults, biliary disorders in children are rarely neoplastic and are more commonly rhabdomyosarcoma rather than cholangiocarcinoma. Pediatric biliary disorders may be embryologic or congenital, such as anatomic gallbladder anomalies, anomalous pancreaticobiliary tracts, various cholestatic processes, congenital cystic lesions, or genetic conditions. They may also be benign, such as biliary filling anomalies, biliary motility disorders, and biliary inflammatory and infectious disorders. Distinguishing these entities with a single imaging modality is challenging. US is the primary imaging modality for initial evaluation of biliary abnormalities in children, due to its wide availability, lack of ionizing radiation, and low cost and because it requires no sedation. Other examinations such as MRI, CT, and nuclear medicine examinations may provide anatomic and functional information to narrow the diagnosis further. Hepatobiliary-specific contrast material with MRI can provide better assessment of biliary anatomy on delayed images than can traditional MRI contrast material. MR cholangiopancreatography (MRCP) allows visualization of the intra- and extrahepatic biliary ducts, which may not be possible with endoscopic retrograde cholangiopancreatography (ERCP). Suspected biliary atresia requires multiple modalities for diagnosis and timely treatment. Determining the type of choledochal cyst calls for a combination of initial US and MRCP. Many benign and malignant biliary masses require biopsy for definitive diagnosis. Knowledge of the imaging appearances of different pediatric biliary abnormalities is necessary for appropriate imaging workup, providing a diagnosis or differential diagnosis, and guiding appropriate management. ©RSNA, 2024 Test Your Knowledge questions for this article are available in the supplemental material.

1 October 2023 in RadioGraphics
Verified
Journal Article
Closed access
LHLaura K. Harper
Laura K. Harper
MCMolly B. Carnahan
Molly B. Carnahan
ABAsha A. Bhatt
Asha A. Bhatt
CSCurtis L. Simmons
Curtis L. Simmons
BPBhavika K. Patel
Bhavika K. Patel
RSRichard Sharpe
Richard Sharpe
High-risk lesions of the breast are frequently encountered in percutaneous biopsy specimens. While benign, these lesions have historically undergone surgical excision due to their potential to be upgraded to malignancy. However, there is emerging evidence that a tailored management approach should be considered to reduce overtreatment of these lesions. Flat epithelial atypia (FEA) and atypical ductal hyperplasia (ADH) are two of the most commonly encountered high-risk lesions. FEA has been shown to have a relatively low rate of progression to malignancy, and some guidelines are now recommending observation over routine excision in select cases. Selective observation may be reasonable in cases where the target lesion is small and completely removed at biopsy and when there are no underlying risk factors, such as a history of breast cancer or genetic mutation or concurrent ADH. ADH has the highest potential upgrade rate to malignancy of all the high-risk lesions. Most society guidelines continue to recommend surgical excision of this lesion. More recently, some literature suggests that ADH lesions that appear completely removed at biopsy, involve limited foci (less than two or three) with no necrosis or significant atypia, manifest as a small group of mammographic calcifications, or demonstrate no enhancement at MRI may be reasonable for observation. Ultimately, management of all high-risk lesions must be based on a multidisciplinary approach that considers all patient, radiologic, clinical, and histopathologic factors. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material.

1 January 2023 in RadioGraphics
Verified
Journal Article
Closed access
LHLaura K. Harper
Laura K. Harper
CSCurtis L. Simmons
Curtis L. Simmons
GWGenevieve A. Woodard
Genevieve A. Woodard
MSMalvika H. Solanki
Malvika H. Solanki
ABAsha A. Bhatt
Asha A. Bhatt
Breast masses in children and adolescents are rare and predominantly benign, and knowledge of the clinical presentation and imaging features of the various stages of normal development and mass-for... Breast masses in children and adolescents are uncommon, and the spectrum of pediatric breast masses is predominantly benign and different from that in adults. Knowledge of the clinical presentation...

3 November 2025 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
TRTariq Rashid
Tariq Rashid
AKAditya Khurana
Aditya Khurana
AZAlan Zhu
Alan Zhu
DSDavid Supeck
David Supeck
LHLaura Harper
Laura Harper
RSRichard Sharpe
Richard Sharpe

20 October 2020 in Journal of Breast Imaging
Verified
Journal Article
Open access
CSCurtis L Simmons
Curtis L Simmons
LHLaura K Harper
Laura K Harper
KHKathryn J Holst
Kathryn J Holst
NBNathan J Brinkman
Nathan J Brinkman
CLChristine U Lee
Christine U Lee
Buffered lidocaine is a local anesthetic option during percutaneous needle-directed procedures in the breast. At our institution, sodium bicarbonate (the buffer) is dispensed in volumes that frequently lead to medical waste and shortages. In this study, we describe how moving the buffering of lidocaine from the procedure room to our clinical hospital pharmacy results in a reduction in costs and improves satisfaction across the breast radiology department. While cost savings are difficult to tease out in practices that opt for bundled payments, we were able to access pricing and supply data and coordinate with our pharmacy to change our practice. Making these changes saves our practice $26 000 a year and allows us to continue to offer buffered lidocaine even during sodium bicarbonate shortages. This manuscript describes how these changes came about and their economic impact.

1 May 2022 in JCO Precision Oncology
Verified
Journal Article
Open access
EGErin Goode
Erin Goode
LMLiliana Montoya
Liliana Montoya
EGEric Graham
Eric Graham
BPBrianna Pruniski
Brianna Pruniski
CSCurtis Simmons
Curtis Simmons
RMRoss Mangum
Ross Mangum
SHH medulloblastoma from GNAS mutation (molecular profiling confirmation) with osteoma cutis & syndromic features.